FDA Inspection 1210865 — Regis Peffault de Latour, M.D.
The FDA completed an inspection of Regis Peffault de Latour, M.D. on July 13, 2023 in Paris Cedex 10. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paris Cedex 10 (France)
Additional Details
Clinical Investigator (CI)